{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:29:18Z","timestamp":1779247758587,"version":"3.51.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Medical Innovation Hub"},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109103h0003"],"award-info":[{"award-number":["JP17ek0109103h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate metabolite alterations in the plasma of SLE patients to identify novel biomarkers and provide insight into SLE pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with SLE (n\u2009=\u200941, discovery cohort and n\u2009=\u200937, replication cohort), healthy controls (n\u2009=\u200930 and n\u2009=\u200929) and patients with RA (n\u2009=\u200919, disease control) were recruited. Metabolic profiles of the plasma samples were analysed using liquid chromatography-time-of-flight mass spectrometry and capillary electrophoresis-time-of-flight mass spectrometry. Transcriptome data was analysed using RNA-sequencing for 18 immune cell subsets. The importance of histidine (His) in plasmablast differentiation was investigated by using mouse splenic B cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrate that a specific amino acid combination including His can effectively distinguish between SLE patients and healthy controls. Random forest and partial least squares-discriminant analysis identified His as an effective classifier for SLE patients. A decrease in His plasma levels correlated with damage accrual independent of prednisolone dosage and type I IFN signature. The oxidative phosphorylation signature in plasmablasts negatively correlated with His levels. We also showed that plasmablast differentiation induced by innate immune signals was dependent on His.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma His levels are a potential biomarker for SLE patients and are associated with damage accrual. Our data suggest the importance of His as a pathogenic metabolite in SLE pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac338","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:30:02Z","timestamp":1654939802000},"page":"905-913","source":"Crossref","is-referenced-by-count":14,"title":["Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-0760","authenticated-orcid":false,"given":"Yukiko","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"},{"name":"Department of Palliative Medicine"},{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University , Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8312-9309","authenticated-orcid":false,"given":"Yusuke","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"},{"name":"Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN , Yokohama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineto","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN , Yokohama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kochi","sequence":"additional","affiliation":[{"name":"Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN , Yokohama"},{"name":"Department of Genomic Function and Diversity, Tokyo Medical and Dental University , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaho","family":"Endo","sequence":"additional","affiliation":[{"name":"Medical Sciences Innovation Hub Program, Cluster for Science, Technology and Innovation Hub, RIKEN , Yokohama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Miki","sequence":"additional","affiliation":[{"name":"Medical Sciences Innovation Hub Program, Cluster for Science, Technology and Innovation Hub, RIKEN , Yokohama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sakurada","sequence":"additional","affiliation":[{"name":"Medical Sciences Innovation Hub Program, Cluster for Science, Technology and Innovation Hub, RIKEN , Yokohama"},{"name":"Department of Extended Intelligence for Medicine, The Ishii-Ishibashi Laboratory, Keio University School of Medicine Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN , Yokohama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"2026041420130100000_keac338-B1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2026041420130100000_keac338-B2","first-page":"148","article-title":"GC\/MS-based metabolomics detects metabolic alterations in serum from SLE patients","volume":"32","author":"Saegusa","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2026041420130100000_keac338-B3","doi-asserted-by":"crossref","first-page":"e37210","DOI":"10.1371\/journal.pone.0037210","article-title":"Metabolic disturbances associated with systemic lupus erythematosus","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"2026041420130100000_keac338-B4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/0961203311418707","article-title":"1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus","volume":"20","author":"Ouyang","year":"2011","journal-title":"Lupus"},{"key":"2026041420130100000_keac338-B5","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar3530","article-title":"Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis","volume":"13","author":"Romick-Rosendale","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2026041420130100000_keac338-B6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fimmu.2019.00976","article-title":"Fecal metabolomics and potential biomarkers for systemic lupus erythematosus","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"2026041420130100000_keac338-B7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3109\/14397595.2016.1158895","article-title":"Serum metabolomic profiling in patients with systemic lupus erythematosus by GC\/MS","volume":"26","author":"Yan","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2026041420130100000_keac338-B8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026041420130100000_keac338-B9","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026041420130100000_keac338-B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2026041420130100000_keac338-B11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026041420130100000_keac338-B12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat Protoc"},{"key":"2026041420130100000_keac338-B13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"2026041420130100000_keac338-B14","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI108033","article-title":"Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity","volume":"55","author":"Gerber","year":"1975","journal-title":"J Clin Invest"},{"key":"2026041420130100000_keac338-B15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026041420130100000_keac338-B16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/ard.2008.093146","article-title":"Lack of association between the interferon-\u03b1 signature and longitudinal changes in disease activity in systemic lupus erythematosus","volume":"68","author":"Landolt-Marticorena","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026041420130100000_keac338-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02264-2","article-title":"Caution in studying and interpreting the lupus metabolome","volume":"22","author":"Zhang","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026041420130100000_keac338-B18","doi-asserted-by":"crossref","first-page":"e0159384","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One"},{"key":"2026041420130100000_keac338-B19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0961203317751860","article-title":"Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever","volume":"27","author":"Kim","year":"2018","journal-title":"Lupus"},{"key":"2026041420130100000_keac338-B20","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/acs.jproteome.8b00192","article-title":"NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis","volume":"17","author":"Guleria","year":"2018","journal-title":"J Proteome Res"},{"key":"2026041420130100000_keac338-B21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.1601908","article-title":"Metabolic reprogramming commits differentiation of human CD27 + IgD + B cells to plasmablasts or CD27 \u2212 IgD \u2212 cells","volume":"199","author":"Torigoe","year":"2017","journal-title":"J. Immunol"},{"key":"2026041420130100000_keac338-B22","article-title":"An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus","author":"Sumikawa","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026041420130100000_keac338-B23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2020-219209","article-title":"Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus","volume":"80","author":"Yin","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026041420130100000_keac338-B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2014.08.011","article-title":"The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production","volume":"41","author":"Kobayashi","year":"2014","journal-title":"Immunity"},{"key":"2026041420130100000_keac338-B25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1073\/pnas.1222798110","article-title":"Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus","volume":"110","author":"Baccala","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026041420130100000_keac338-B26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ng.3809","article-title":"Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites","volume":"49","author":"Long","year":"2017","journal-title":"Nat Genet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac338\/44244585\/keac338.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/905\/49031786\/keac338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/905\/49031786\/keac338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:22:07Z","timestamp":1776212527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/2\/905\/6605851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac338","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,6,11]]}}}